LifeMD, Inc. (NASDAQ: LFMD) reported Q2 EPS of $0.05, $0.19 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $35.95 million versus the consensus estimate of $35.17 million.

GUIDANCE:

LifeMD, Inc. sees Q3 2023 revenue of $37.5-38.5 million, versus the consensus of $37.31 million.

LifeMD, Inc. sees FY2023 revenue of $146-152 million, versus the consensus of $144.7 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.